GE HealthCare is acquiring icometrix to expand its AI-powered MRI neuroimaging capabilities and integrate advanced analytics into its global product ecosystem.
Key Details
- 1GE HealthCare has signed a deal to acquire Belgium-based icometrix, specialist in AI software for neurological MRI analysis.
- 2icometrix's icobrain platform supports Alzheimer’s disease and multiple sclerosis imaging, including ARIA detection for amyloid therapies.
- 3The acquisition aims to integrate icobrain with GE’s MRI systems and make the technology vendor-agnostic for broader clinical adoption.
- 4icometrix has existing partnerships with major industry players like Siemens, Nuance, and the American College of Radiology.
- 5Industry analysts highlight this move as part of a broader consolidation wave in the radiology AI sector, driven by demand for integrated workflow solutions and precision neurology.
- 6Financial terms of the deal were not disclosed.
Why It Matters
This acquisition highlights the trend of major imaging OEMs consolidating differentiated AI capabilities for end-to-end integration, especially in high-growth areas like neurology. Seamless workflow integration and standardized tools for ARIA detection will be critical as MRI volumes rise, making this a strategic move for GE and the wider radiology AI field.
Source
AuntMinnie
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•Radiology Business
NYC Health + Hospitals CEO Considers AI to Replace Radiologists
NYC Health + Hospitals CEO suggests AI could partially replace radiologists, pending regulatory approval.
•AuntMinnie
AI Mammography Tool Shows No Significant Benefit in Single-Reader U.S. Study
A real-world study found no significant improvement in breast cancer detection or recall rates with an FDA-approved AI mammography tool in a single-reader setting.